Effect of Butyrate Supplement on Rheumatoid Arthritis

Summary

This study is a pilot study to evaluate the safety and efficacy of administering butyrate supplement on rheumatoid arthritis patients. Thirty participants will be included to receive butyrate supplement for 12 weeks. Changes of immune cell subtypes, markers of intestinal damage, intestinal flora and other laboratory indicators will be monitored.

Timeline

Start

2022-08-23

Primary completion

2023-10-01

Completion

2024-06-15

Drugs

Indications